Evidence map›Paper›PMID 34665311›Full record

GuidelineSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2022

Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/guidance on the use of clinically assisted nutrition in patients with advanced cancer.

Bryony Alderman, Lindsey Allan, Koji Amano, Carole Bouleuc, Mellar Davis, Stephanie Lister-Flynn, Sandip Mukhopadhyay, Andrew Davies

Abstract readPractice Guideline
In one paragraph

Guideline in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. SEOM clinical guidelines for cancer anorexia-cachexia syndrome (2023).Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Guideline
  3. Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/guidance on the use of clinically assisted hydration in patients with advanced cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Guideline
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Taste disturbance in patients with advanced cancer: a scoping review of clinical features and complications.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bryony AldermanRoyal Surrey County Hospital, Guildford, UK.
Lindsey AllanRoyal Surrey County Hospital, Guildford, UK.
Koji AmanoDepartment of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan.
Carole BouleucDepartment of Supportive and Palliative Care, Institut Curie, Paris, France.
Mellar DavisPalliative Care Department, Geisinger Medical System, PA, Danville, USA.
Stephanie Lister-FlynnSt Catherine's Hospice, Crawley, UK.
Sandip MukhopadhyayDepartment of Pharmacology, Burdwan Medical College, Burdwan, India.
Andrew DaviesSchool of Medicine, Trinity College Dublin, Dublin, Ireland. andavies@tcd.ie.ORCID http://orcid.org/0000-0003-4207-4799

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe pro vision of clinically assisted nutrition (CAN) in patients with advanced cancer is controversial, and there is a paucity of specific guidance, and so a diversity in clinical practice. Consequently, the Palliative Care Study Group of the Multinational Association of Supportive Care in Cancer (MASCC) formed a Subgroup to develop evidence-based guidance on the use CAN in patients with advanced cancer.

methodsThis guidance was developed in accordance with the MASCC Guidelines Policy. A search strategy for Medline was developed, and the Cochrane Database of Systematic Reviews and the Cochrane Central Register of Controlled Trials were explored for relevant reviews/trials respectively. The outcomes of the review were categorised by the level of evidence, and a "category of guideline" based on the level of evidence (i.e. "recommendation", "suggestion", or "no guideline possible").

resultsThe Subgroup produced 11 suggestions, and 1 recommendation (due to the paucity of evidence). These outcomes relate to assessment of patients, indications for CAN, contraindications for CAN, procedures for initiating CAN, and re-assessment of patients.

conclusionsThis guidance provides a framework for the use of CAN in advanced cancer, although every patient needs individualised management.

Indexed as

NeoplasmsHumansNutritional StatusPalliative CareAdvanced cancerClinically assisted nutritionNeoplasmsPalliative carePractice guideline

Identifiers

PMID34665311
PMCPMC8857106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.